# RxSight, Inc. (RXST) MD&A by fiscal year

Verbatim Item 7 Management's Discussion and Analysis sections from RxSight, Inc.'s 10-K filings, one page per fiscal year. Extracted from SEC filings with the same bounded parser for every year. Filer text, not grepcent analysis or investment advice.

- [FY 2025 MD&A](/company/RXST/mda/fy2025/): filed 2026-02-25; accession 0001193125-26-071775 (https://www.sec.gov/Archives/edgar/data/1111485/000119312526071775/rxst-20251231.htm); latest 10-K
- [FY 2024 MD&A](/company/RXST/mda/fy2024/): filed 2025-02-25; accession 0000950170-25-026681 (https://www.sec.gov/Archives/edgar/data/1111485/000095017025026681/rxst-20241231.htm)
- [FY 2023 MD&A](/company/RXST/mda/fy2023/): filed 2024-02-28; accession 0000950170-24-022073 (https://www.sec.gov/Archives/edgar/data/1111485/000095017024022073/rxst-20231231.htm)
- [FY 2022 MD&A](/company/RXST/mda/fy2022/): filed 2023-03-06; accession 0000950170-23-006237 (https://www.sec.gov/Archives/edgar/data/1111485/000095017023006237/rxst-20221231.htm)
- [FY 2021 MD&A](/company/RXST/mda/fy2021/): filed 2022-03-08; accession 0000950170-22-003135 (https://www.sec.gov/Archives/edgar/data/1111485/000095017022003135/rxst-20211231.htm)

Back to /company/RXST/